AA
TMO icon

AlphaCentric Advisors’s Thermo Fisher Scientific TMO Stock Holding History

AlphaCentric Advisors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$2.17M Buy
+4,175
New +$2.3M 2.17% 7
2021
Q4 		– Sell
-128
Closed -$73K – 271
2021
Q3 		$73K Hold
128
– – 0.02% 184
2021
Q2 		$65K Buy
128
+16
+14% +$7.55K 0.02% 199
2021
Q1 		$51K Sell
112
-4
-3% -$1.91K 0.02% 190
2020
Q4 		$54K Buy
+116
New +$54.4K 0.02% 177

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AlphaCentric Advisors's TMO Position: Q4 2024 in Review

AlphaCentric Advisors opened a new position in Thermo Fisher Scientific (TMO) in Q4 2024: 4,175 shares worth $2.17M. The stake represents 2.17% of the portfolio and ranks #7 among its holdings. This is a return to the name: AlphaCentric Advisors previously reported a position in TMO as recently as Q3 2021.

AlphaCentric Advisors first reported a position in TMO in Q4 2020 and has held it in 5 quarters since. 2,616 funds tracked by Wall St. Rank hold TMO as of Q4 2024.

  • AlphaCentric Advisors held 4,175 shares of Thermo Fisher Scientific worth $2.17M as of Q4 2024.
  • Thermo Fisher Scientific was a new AlphaCentric Advisors position in Q4 2024.
  • Thermo Fisher Scientific made up 2.17% of AlphaCentric Advisors's portfolio in Q4 2024, its #7 holding.
  • AlphaCentric Advisors first reported a position in Thermo Fisher Scientific in Q4 2020 and has held it in 5 quarters since.
  • 2,616 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2024.

Based on AlphaCentric Advisors's 13F filing for Q4 2024, filed 31 Jan 2025.